Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 0 lead-in Trial of Pitavastatin in Primary and Recurrent Glioblastoma Patients

NCT05977738 is registered in ClinicalTrials.gov with C.Dirven as lead sponsor.

NCT NCT05977738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05977738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 0 lead-in Trial of Pitavastatin in Primary and Recurrent Glioblastoma Patients
Lead sponsor
C.Dirven
Phase
Phase 1
Overall status
Completed
Start date
January 18, 2024
Completion date
July 19, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, adult, recurrent glioblastoma